UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032564
Receipt number R000036943
Scientific Title A prospective study of the effectiveness of mesenchymal stem cell therapy for lymphedema
Date of disclosure of the study information 2018/05/14
Last modified on 2020/05/13 13:50:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective study of the effectiveness of mesenchymal stem cell therapy for lymphedema

Acronym

Study of MSC for lymphedema

Scientific Title

A prospective study of the effectiveness of mesenchymal stem cell therapy for lymphedema

Scientific Title:Acronym

Study of MSC for lymphedema

Region

Japan


Condition

Condition

Lower limb lymphedema

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and efficacy of transplant of autologous culutured adipose derived stem cells on secondary lower limb lymphedema.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Immediate pre-intervantion and 1, 3, 6 months post intervention

volume of edema
Visual analogue scale (VAS) of pain
Skin stiffness
Adverse event:Clavien-dindo classification

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Patients of Unilateral lower limb lymphedema
with histerectomy and pelvic lymph node dissection due to cervical and/or uterine cancerwithout radiation therapy.

Key exclusion criteria

Patients with active cancer, deep vein thronbosis and/or lymphedema morphologically classified into hyperplasia.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Keita
Middle name
Last name Inoue

Organization

Avenue Cell Clinic

Division name

Avenue Cell Clinic

Zip code

1070062

Address

Minami Aoyama 3-18-6, Minato-ku, Tokyo Japan

TEL

0120-382-300

Email

kinoue-tky@umin.ac.jp


Public contact

Name of contact person

1st name Keita
Middle name
Last name Inoue

Organization

Avenue Cell Clinic

Division name

Avenue Cell Clinic

Zip code

1070062

Address

Minami Aoyama 3-18-6, Minato-ku, Tokyo Japan

TEL

0120-382-300

Homepage URL


Email

kinoue-tky@umin.ac.jp


Sponsor or person

Institute

Avenue Cell Clinic

Institute

Department

Personal name



Funding Source

Organization

Avenue Cell Clinic

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

NPO MINS committee

Address

5-20-9-401 Mita, Minato-Ku, Tokyo, JAPAN

Tel

03-6416-1868

Email

npo-mins@j-irb.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 04 Month 19 Day

Date of IRB

2018 Year 04 Month 23 Day

Anticipated trial start date

2018 Year 05 Month 01 Day

Last follow-up date

2019 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Immediate pre-intervantion and 1, 3, 6 months post intervention

volume of edema
Visual analogue scale (VAS) of pain
Skin stiffness
Adverse event:Clavien-dindo classification


Management information

Registered date

2018 Year 05 Month 12 Day

Last modified on

2020 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036943


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name